McKinsey February 18, 2025
Ari Perl, Chris Eakins, Richard Bartlett, with Adrian Lo and Shayne Skov,

Leading medtech companies are embarking on bold transformations and evolving their operating models to unlock sustainable growth and create efficiencies.

The medtech sector continues to face challenges in achieving profitable growth, causing some companies to embark on bold transformations to unlock value. Value creation and potential efficiencies are difficult to capture because they are often deeply interconnected across functions, requiring an evolved operating model and cross-functional collaboration to unlock. Executing a successful transformation in medtech can catalyze change by helping companies refocus on sustainable growth, reigniting a cycle of efficiency improvement and driving stronger performance overall.

Continuing challenges with growth and margin expansion in medtech

As discussed in Medtech Pulse: Thriving in the next decade, the medtech sector has struggled...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO
Device industry scrambles amid concern FDA layoffs will cause delays
Pharma and medtech industry reacts to FDA, CDC and NIH job cuts
Avante appoints new CEO under Staple Street ownership
Micro-X gets $16 million contract to develop mobile full-body CT

Share This Article